Market Snapshot
S&P Futures
4,276.75
Dow Futures
33,884
Nasdaq Futures
13,514.5
Lexicon Pharmaceuticals, Inc. (LXRX) stock declined over -0.82% intraday to trade at $3.035 a share on NASDAQ. The stock opened with a loss of -12.79% at $3.48 and touched an intraday high of $3.31, falling -7.47% against the last close of $3.28. The stock went to a low of $3.06 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-17 | $3.48 | $3.31 | $3.06 | $3.06 | 1,409,260 |
2022-08-16 | $3.48 | $3.48 | $3.25 | $3.28 | 1,061,600 |
2022-08-15 | $3.18 | $3.46 | $3.15 | $3.43 | 1,639,100 |
2022-08-12 | $2.9 | $3.27 | $2.79 | $3.17 | 3,264,200 |
2022-08-11 | $2.77 | $2.86 | $2.71 | $2.76 | 1,193,000 |
2022-08-10 | $2.65 | $2.81 | $2.59 | $2.78 | 1,217,100 |
2022-08-09 | $2.67 | $2.67 | $2.5 | $2.56 | 1,268,100 |
2022-08-08 | $2.87 | $3.02 | $2.47 | $2.58 | 2,882,700 |
2022-08-05 | $2.62 | $2.88 | $2.6 | $2.83 | 2,739,700 |
2022-08-04 | $2.69 | $2.79 | $2.64 | $2.69 | 1,997,700 |
2445 Technology Forest Boulevard
11th Floor
The Woodlands, TX 77381
United States
Webiste:LXRX
Employees-
Beta1.51
Sales or Revenue308 Thousands
5Y Sales Change-67.3%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) stock price is $3.035 as of the last check on Wednesday, August 17. During the trading session, LXRX stock reached the peak price of $3.31 while $3.06 was the lowest point it dropped to.
The NASDAQ listed LXRX is part of Biotechnology industry that operates in the broader Health Care sector. Lexicon Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.
Mr. Brian T. Crum
VP, Gen. Counsel & Sec.
Mr. Lonnel Coats
CEO & Director
Mr. Jeffrey L. Wade J.D.
Pres & CFO
Mr. Brian T. Crum
Sr. VP, Gen. Counsel & Sec.
LXRX stock traded closed the last session at $3.06, which is -$0.02499999999999991 or -0.8169934640522847% lower than its previous close of $3.28. LXRX's current trading price is 133.59% lower than its 52-week high of $6.33 where as its distance from 52-week low of 1.31% is -51.66%.
Number of LXRX employees currently stands at -. LXRX operates from 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX 77381, United States.
Official Webiste of $LXRX is: https://www.lexpharma.com
LXRX could be contacted at LXRX operates from 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX 77381, United States, or at phone #281 863 3000 and can also be accessed through its website.
LXRX stock volume for the day was 461,173 shares while in the previous session number of LXRX shares traded was 1,409,260 . The average number of LXRX shares traded daily for last 3 months was 1.68 Million.
The percentage change in LXRX stock occurred in the recent session was -0.8169934640522847% while the dollar amount for the price change in LXRX stock was -$0.02499999999999991.
In the recent session, the day high for LXRX stock was $3.31 while the low for LXRX stock touched on the day was $3.06.
The market value of LXRX currently stands at 489.2 Million with its latest stock price at $3.035 and 149.62 Million of its shares outstanding.